USA - engelsk - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - nafarelin acetate (unii: 8enz0qjw4h) (nafarelin - unii:1x0094v6jv) - nafarelin 2 mg in 1 ml - (for endometriosis, see reverse side ) synarel is indicated for treatment of central precocious puberty (cpp) (gonadotropin-dependent precocious puberty) in children of both sexes. the diagnosis of central precocious puberty (cpp) is suspected when premature development of secondary sexual characteristics occurs at or before the age of 8 years in girls and 9 years in boys, and is accompanied by significant advancement of bone age and/or a poor adult height prediction. the diagnosis should be confirmed by pubertal gonadal sex steroid levels and a pubertal lh response to stimulation by native gnrh. pelvic ultrasound assessment in girls usually reveals enlarged uterus and ovaries, the latter often with multiple cystic formations. magnetic resonance imaging or ct-scanning of the brain is recommended to detect hypothalamic or pituitary tumors, or anatomical changes associated with increased intracranial pressure. other causes of sexual precocity, such as congenital adrenal hyperplasia, testotoxicosis, testicular

Israel - engelsk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - nafarelin acetate - nasal solution - nafarelin acetate 2 mg/ml - nafarelin - nafarelin - - controlled ovarian stimulation programmes prior to in-vitro fertilisation.- hormonal management of endometriosis, including pain relief and reduction of endometrial lesions. - uterine fibroids.

Israel - engelsk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - nafarelin acetate - nasal solution - nafarelin acetate 2 mg/ml - nafarelin - - controlled ovarian stimulation programmes prior to in-vitro fertilisation.- hormonal management of endometriosis, including pain relief and reduction of endometrial lesions. - uterine fibroids.

Israel - hebraisk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - nafarelin acetate - תמיסה לאף - nafarelin acetate 2 mg/ml - nafarelin - nafarelin - - controlled ovarian stimulation programmes prior to in-vitro fertilisation.- hormonal management of endometriosis, including pain relief and reduction of endometrial lesions. - uterine fibroids.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - nafarelin, quantity: 2 mg/ml - spray, solution - excipient ingredients: benzalkonium chloride; sorbitol; glacial acetic acid; hydrochloric acid; purified water; sodium hydroxide - indications as at 31 august 1995. synarel is indicated for the hormonal management of visually proven endometriosis, including pain relief and reduction of endometriotic lesions and for use in controlled ovarian stimulation programmes prior to in-vitro fertilisation, under the supervision of an infertility specialist.

Japan - engelsk - すりの適正使用協議会 RAD-AR Council, Japan

fuji pharmaceutical co.,ltd. - nafarelin acetate hydrate - limpid and colorless nasal solution

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - nafarelin acetate - spray - 200microgram/1dose

Israel - hebraisk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - nafarelin acetate - תמיסה לאף - nafarelin acetate 2 mg/ml - nafarelin

Canada - fransk - Health Canada

pfizer canada ulc - nafaréline (acétate de nafaréline) - aérosol à dose mesurée - 200mcg - nafaréline (acétate de nafaréline) 200mcg - gonadotropins and antigonadotropins

Canada - engelsk - Health Canada

pfizer canada ulc - nafarelin (nafarelin acetate) - metered-dose aerosol - 200mcg - nafarelin (nafarelin acetate) 200mcg - gonadotropins and antigonadotropins